Raphael Pharmaceutical Inc.
RAPH · OTCMCIK 1415397fmd_1SRXYXYWY1DRYF1S8F2SSJAQHGManufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Jan 01, 2020 to Jun 30, 2026, 25 periods
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Research and development | 0 | 1 | 1 | 1 | 1 | 1 |
| Operating income | (1) | (2) | (3) | (1) | (2) | (1) |
| Other non-operating income (expense) | (0) | 0 | (0) | (0) | (0) | (0) |
| Net income | (1) | (2) | (3) | (1) | (2) | (1) |
| Net income to common shareholders | (1) | (2) | (3) | (1) | – | – |